VENLAFAXINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 11 adverse event reports in the FDA FAERS database where VENLAFAXINE was used for Psoriasis.
Most Reported Side Effects for VENLAFAXINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 5,408 | 11.3% | 156 | 1,052 |
| Toxicity to various agents | 3,917 | 8.2% | 2,179 | 1,892 |
| Nausea | 2,989 | 6.2% | 257 | 624 |
| Completed suicide | 2,929 | 6.1% | 2,914 | 920 |
| Headache | 2,668 | 5.6% | 335 | 452 |
| Dizziness | 2,426 | 5.1% | 229 | 476 |
| Off label use | 2,310 | 4.8% | 227 | 637 |
| Overdose | 2,220 | 4.6% | 592 | 1,154 |
| Intentional overdose | 2,187 | 4.6% | 196 | 1,597 |
| Fatigue | 2,153 | 4.5% | 302 | 505 |
| Anxiety | 2,059 | 4.3% | 64 | 559 |
| Hyperhidrosis | 1,932 | 4.0% | 117 | 348 |
| Depression | 1,921 | 4.0% | 102 | 560 |
| Suicide attempt | 1,893 | 4.0% | 53 | 1,181 |
| Drug interaction | 1,860 | 3.9% | 270 | 859 |
Other Indications for VENLAFAXINE
Product used for unknown indication (15,609)
Depression (11,868)
Anxiety (2,564)
Major depression (1,380)
Bipolar disorder (757)
Migraine (706)
Suicide attempt (475)
Anxiety disorder (443)
Antidepressant therapy (441)
Generalised anxiety disorder (317)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)